Disc Medicine names new director and new general counsel
5 January 2022 -
Disc Medicine, a US-based clinical-stage biopharmaceutical company, announced on Tuesday that it has named Jay T Backstrom, MD., MP as its director and Rahul Khara, Pharm.D., JD, as its general counsel.
Dr Backstrom has served executive vice president, head of Research and Development at Acceleron Pharma. He has more than 30 years of experience in research and development and was previously chief medical officer (and head of Regulatory Affairs) at Celgene. He has held the position of vice president of Global Medical Affairs and Safety at Pharmion. He started his career at Marion Merrell Dow and continued as part of its successor companies including Hoechst Marion Roussel. He has also held the position of staff physician and medical director of the Samuel U. Rodgers Community Health Center in Kansas City, Missouri.
Dr Khara has held the position of vice president, Legal and chief compliance officer at Acceleron Pharma. He has served at the law firms of Arnold & Porter LLP and Sidley Austin LLP, working with biopharma companies in various stages of development to navigate legal issues related to the clinical development of new assets, launch of new drug products, business development transactions, compliance, and enforcement.
Suliman Named CEO at ReCode Therapeutics
Mullarkey Named CEO at Bluestar Genomics
PaxMedica receives South African regulatory approval for PAX-101 clinical trial in patients with Long COVID-19 Syndrome
Amador Bioscience announces new chief technology officer appointment
Anebulo Pharmaceuticals Names Allen as CEO and Director
SI Group names new senior vice president and chief financial officer
KalVista Pharmaceuticals announces inducement grants to four new employees pursuant to Nasdaq Listing Rule 5635(c)(4)
Iveric Bio announces non-statutory stock options to eight new employees under Nasdaq Listing Rule 5635(c)(4)
Faron Pharmaceuticals names new chief medical officer
Biosion names new chief strategy officer and head of China business development
CytRx Names Snowdy as Chief Executive Officer
4D Pharma Names Doyle as Chief Financial Officer
Legend Biotech Names CEO, CFO Huang to the Board of Directors
EOFlow Co's United States subsidiary signs contract with Zihipp Limited